Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 602
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT04745559 | Optimizing Cellular and Humoral Immunity by Vaccinating With PCV13 Before and After CAR-T Therapy | ||
| NCT00005640 | Lymphatic Mapping and Sentinel Lymph Node Biopsy in the Treatment of Colorectal Cancer | ||
| NCT00012350 | Phase II Evaluation of FTase Inhibitor (FTI)in Treatment of Advanced Multiple Myeloma | ||
| NCT00400569 | Phase II Study of Sunitinib Malate for Metastatic and/or Surgically Unresectable Soft Tissue Sarcoma | ||
| NCT04335799 | Reducing Weight and Elevated Stress Levels Using Educational and Behavioral Tools | ||
| NCT04620681 | CD8 Depleted, Non-engrafting, HLA Mismatched Unrelated Infusion With MDS and Secondary AML | ||
| NCT01841021 | Pilot Study of Brentuximab Vedotin in Relapsed/Refractory Peripheral T-Cell Lymphoma Expressing CD30 | ||
| NCT03232411 | Biobank for African American Prostate Cancer Research in Florida | ||
| NCT00720629 | Visilizumab for the Prevention of Graft-versus-Host Disease After Allogeneic Hematopoietic Cell Transplantation | ||
| NCT00879073 | Study Bendamustine Concurrent Whole Brain Radiation Brain Metastases From Solid Tumors | ||
| NCT02745756 | A Combined Cell Therapy Approach to the Treatment of Neuroblastoma | ||
| NCT06109467 | Neratinib In Combination With Chemotherapy/Trastuzumab/Pembrolizumab In HER2 Gastroesophageal Cancer | ||
| NCT05645471 | Together After Cancer | ||
| NCT03071406 | Randomized Study of Nivolumab+Ipilimumab+/- SBRT for Metastatic Merkel Cell Carcinoma | ||
| NCT06104592 | Single-Arm Comprehensive Ablative Bridging Irradiation I Prior to CD19 CAR-T In High-Risk R/R LBCL | ||
| NCT05177211 | Fedratinib in Myelodysplastic /Myeloproliferative Neoplasms (MDS/MPNs) and Chronic Neutrophilic Leukemia (CNL) | ||
| NCT02451735 | Genetic Counseling for Breast Cancer Survivors (GC for BC) | ||
| NCT02283359 | Selinexor in Combination With Irinotecan in Adenocarcinoma of Stomach and Distal Esophagus | ||
| NCT03906110 | Community Colorectal Cancer Awareness, Research, Education & Screening (C-CARES) | ||
| NCT05798780 | The ENHANCE Study: Exercise and Nutrition in Head And Neck CancEr Survivors | ||
| NCT06137274 | Phase 2 Trial of Adaptive Radiotherapy Boost for HNSCC | ||
| NCT00868114 | Direct Tumor Injection KLH-Pulsed Dendritic Cells in Unresectable Pancreatic Cancer | ||
| NCT05524935 | Olaparib in Combination With Pembrolizumab for Advanced Uveal Melanoma | ||
| NCT01385956 | SOM 230 and Gemcitabine in Advanced Pancreatic Cancer | ||
| NCT06963346 | Study Investigating Intravesical HDAC Inhibition to Improve Response to Immuno-Oncology Agents | ||
| NCT04714983 | DNX-2440 for Resectable Colorectal Liver Metastasis | ||
| NCT03655756 | pDNA Intralesional Cancer Vaccine for Cutaneous Melanoma | ||
| NCT00598507 | Phase II Trial Of ZK-EPO (ZK 219477) (Sagopilone) In Metastatic Melanoma | ||
| NCT02780609 | Selinexor Plus High-Dose Melphalan (HDM) Before Autologous Hematopoietic Cell Transplantation for Multiple Myeloma | ||
| NCT04562129 | IL2 With Ipilimumab Followed by Nivolumab in Stage 3 or 4 Melanoma Patients | ||
| NCT00665002 | Pilot Trial of a WT-1 Analog Peptide Vaccine in Patients With Myeloid Neoplasms | ||
| NCT05809752 | A First in Human Dose Escalation of Dendritic Cell Vaccine (DCV) | ||
| NCT01450046 | Vitamin E δ-Tocotrienol Multiple Dose in Healthy Subjects | ||
| NCT02415621 | Adaptive Abiraterone Therapy for Metastatic Castration Resistant Prostate Cancer | ||
| NCT01347034 | Radiation Therapy and Intratumoral Autologous Dendritic Cells in Soft Tissue Sarcomas (STS) | ||
| NCT05873439 | Genomically Guided Radiation Dose Personalization in Locally Advanced NSCLC | ||
| NCT07476001 | Phase 2a Study of High-Dose Testosterone Followed by Radioligand Therapy in mCRPC | ||
| NCT02721459 | XL888 + Vemurafenib + Cobimetinib for Unresectable BRAF Mutated Stage III/IV Melanoma | ||
| NCT06760156 | Tafasitamab and Lenalidomide as First Salvage Therapy for Residual Large B Cell Lym | ||
| NCT02403310 | A Study of Selinexor in Combination With Daunorubicin and Cytarabine for Untreated AML | ||
| NCT04585269 | Bright IDEAS - Young Adults Problem-Solving Skills Training | ||
| NCT00049218 | Chemotherapy Followed By Vaccine Therapy in Treating Patients With Extensive-Stage Small Cell Lung Cancer | ||
| NCT05628883 | Proof of Concept of TBio-4101, Lymphodepleting Chemo, IL-2 for Relapsed/Refractory Melanoma | ||
| NCT01497496 | Ofatumumab/Methylprednisolone and Ofatumumab/Lenalidomide for Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) | ||
| NCT03605927 | CD40-L Blockade for Prevention of Acute Graft-Versus-Host Disease | ||
| NCT04163718 | TGR-1202 (Umbralisib) in Treatment Naïve Patients With Chronic Lymphocytic Leukemia (CLL) | ||
| NCT00858403 | Dasatinib in Advanced Non-small Cell Lung Cancer (NSCL) With Ex Vivo and In Vivo Assessment of Tumor Target Modulation | ||
| NCT05677360 | HPV Multilevel Intervention Strategies Targeting Immunization in Community Settings (HPV MISTICS) | ||
| NCT02901548 | Phase 2 Durvalumab (Medi4736) for Bacillus Calmette-Guérin (BCG) Refactory Urothelial Carcinoma in Situ of the Bladder | ||
| NCT00496223 | A Phase I/II Study of Sunitinib and Dacarbazine |
